Cargando…
Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial
BACKGROUND: Patients with schizophrenia can generally manifest a broad variety of primary negative symptoms. The current study aimed to assess the efficacy and tolerability of resveratrol add-on therapy in the treatment of negative symptoms in patients with stable schizophrenia. METHODS: In a random...
Autores principales: | Samaei, Areoo, Moradi, Kamyar, Bagheri, Sayna, Ashraf-Ganjouei, Amir, Alikhani, Rosa, Mousavi, Seiedeh Bentolhoda, Rezaei, Farzin, Akhondzadeh, Shahin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770519/ https://www.ncbi.nlm.nih.gov/pubmed/33372679 http://dx.doi.org/10.1093/ijnp/pyaa006 |
Ejemplares similares
-
Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial
por: Kianimehr, Gilda, et al.
Publicado: (2014) -
Comparison of Caregivers’ Burden among Family Members of Patients with Severe Mental Disorders and Patients with Substance Use Disorder
por: Mihan, Ronak, et al.
Publicado: (2023) -
Efficacy of Spironolactone as an Adjunctive Therapy to Risperidone to Improve Symptoms of Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled, Clinical Trial
por: Zandifar, Atefeh, et al.
Publicado: (2022) -
Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial
por: Rezaei, Farzin, et al.
Publicado: (2015) -
Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trial
por: Akhondzadeh, Shahin, et al.
Publicado: (2003)